Industry Analysis & Industry Trends
The Pharmaceutical Product Manufacturing industry is an important component of the pharmaceutical sector. The major global pharmaceutical groups dominate the local industry, although only a small number are engaged in actives manufacturing (i.e. active pharmaceutical ingredients). An increasing number of firms are limiting their Australian involvement to the later stages of the manufacturing process, such as dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their Australian activities to distribution.
As with the global pharmaceutical industry, the local industry is currently contending with the fallout effects associated with the patent cliff... purchase to read more
Industry Report - Industry Analysis Chapter
The Pharmaceutical Product Manufacturing industry has gradually deteriorated over the past five years as a rapidly changing operating environment has taken its toll on the industry. The key features characterising the industry are intensifying competition from generic products, the demise of the blockbuster era and the passing patent cliff. These factors come at a time when product pipelines are thinning, R&D productivity is declining and costs are escalating. Despite the industry spending double on R&D compared with a decade ago, it is producing less than half the drugs. These variables have stimulated dramatic change in the industry.
A number of other factors are restraining industry growth... purchase to read more